These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2456507)

  • 41. [Antibodies to extractable nuclear antigens in systemic lupus erythematosus].
    Chorzelski T; Błaszczyk M; Jabłońska S; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G
    Przegl Dermatol; 1979; 66(5):457-61. PubMed ID: 316549
    [No Abstract]   [Full Text] [Related]  

  • 42. Antinuclear Antibodies in Systemic Sclerosis: an Update.
    Stochmal A; Czuwara J; Trojanowska M; Rudnicka L
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):40-51. PubMed ID: 30607749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antinuclear antibodies defining autoimmunity pathways.
    Tan EM
    Arthritis Res Ther; 2014 Feb; 16(1):104. PubMed ID: 24517467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antinuclear antibody- and extractable nuclear antigen-related diseases.
    Hiepe F; Dörner T; Burmester G
    Int Arch Allergy Immunol; 2000 Sep; 123(1):5-9. PubMed ID: 11014966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical significance of autoantibodies to soluble intra-cellular protein antigens in systemic connective tissue diseases].
    Abe T; Takano M
    Ryumachi; 1987 Jun; 27(3):203-14. PubMed ID: 2449738
    [No Abstract]   [Full Text] [Related]  

  • 46. Cellular interactions and signalling defects in lupus (1).
    Zouali M; Mageed RA
    Lupus; 2008 Mar; 17(3):236-40. PubMed ID: 18372368
    [No Abstract]   [Full Text] [Related]  

  • 47. Oxygen free radicals and systemic autoimmunity.
    Ahsan H; Ali A; Ali R
    Clin Exp Immunol; 2003 Mar; 131(3):398-404. PubMed ID: 12605691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antinuclear antibodies and cancer: A literature review.
    Vlagea A; Falagan S; Gutiérrez-Gutiérrez G; Moreno-Rubio J; Merino M; Zambrana F; Casado E; Sereno M
    Crit Rev Oncol Hematol; 2018 Jul; 127():42-49. PubMed ID: 29891110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies-like antigen binding characteristics of induced antibodies against polylysine-polyglutamate complex.
    Arif Z; Arjumand S; Ali A; Ali R
    Autoimmunity; 1994; 19(1):7-14. PubMed ID: 7538332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular protein and RNA antigens in autoimmune disease.
    Bernstein RM; Bunn CC; Hughes GR; Francoeur AM; Mathews MB
    Mol Biol Med; 1984 Apr; 2(2):105-20. PubMed ID: 6085392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolving story of autoantibodies in systemic lupus erythematosus.
    Pisetsky DS
    J Autoimmun; 2020 Jun; 110():102356. PubMed ID: 31810857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease.
    Bremer HD; Landegren N; Sjöberg R; Hallgren Å; Renneker S; Lattwein E; Leonard D; Eloranta ML; Rönnblom L; Nordmark G; Nilsson P; Andersson G; Lilliehöök I; Lindblad-Toh K; Kämpe O; Hansson-Hamlin H
    Sci Rep; 2018 Mar; 8(1):4852. PubMed ID: 29556082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microparticles as autoadjuvants in the pathogenesis of SLE.
    Pisetsky DS; Lipsky PE
    Nat Rev Rheumatol; 2010 Jun; 6(6):368-72. PubMed ID: 20458331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent developments in the understanding of antinuclear autoantibodies.
    Casiano CA; Tan EM
    Int Arch Allergy Immunol; 1996 Dec; 111(4):308-13. PubMed ID: 8957101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibody-defined epitopes on nuclear antigens are conserved, conformation-dependent and active site regions.
    Tan EM; Muro Y; Pollard KM
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S27-31. PubMed ID: 7539349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of anti-DNA antibodies with synthetic polyanionic antigens.
    Weber K; Hawruk E; DeBari VA
    J Autoimmun; 1989 Dec; 2(6):851-9. PubMed ID: 2482741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [SLE caused by DNase 1 gene mutation].
    Tao K; Yasutomo K
    Nihon Rinsho; 2005 May; 63 Suppl 5():205-9. PubMed ID: 15954350
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical aspects of indirect immunofluorescence for autoimmune diseases.
    Ghanadan A; Saghazadeh A; Jahanzad I; Rezaei N
    Expert Rev Clin Immunol; 2015 May; 11(5):597-616. PubMed ID: 25786676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antinuclear antibodies to RNA-binding proteins in SLE.
    Maddison PJ
    Rheumatol Int; 1991; 11(3):109-12. PubMed ID: 1754811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell cycle-associated autoantibodies: markers for autoimmunity and probes for molecular cell biology.
    Yeo JP; Toh BH
    Autoimmunity; 1994; 18(4):291-300. PubMed ID: 7858115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.